Applicability of PDCA cycle in standardization of outpatient prescriptions

doi:10.19803/j.1672-8629.2022.09.22

Abstract

Abstract: Objective To explore the applicability of the PDCA cycle in standardizing outpatient prescriptions in our hospital so as to reduce medication errors and drug costs. Methods A total of 2 000 outpatient prescriptions were selected using the random number table method between November 1, 2019 and June 30, 2020 (before intervention). The rate of qualification of outpatient prescriptions and the distribution and proportion of substandard ones were calculated. Based on the results of analysis, the PDCA cycle was adopted for intervention. 1 000 problematic outpatient prescriptions were statistically analyzed between July 1, 2020 and October 31, 2020 (after intervention). Results From November 1, 2019 to June 30, 2020, the rate of qualification of prescriptions averaged 88.8%, which failed to meet the national requirement (over 95%). After the intervention by the PDCA cycle, the rate of qualification of prescriptions not only rose to 95.70% between July 1, 2020 and October 31, 2020, which met the national requirement, but maintained a trend of month-on-month increase, from the lowest (86.27%) before intervention to the highest (96.38%) after the intervention. The achievement rate of tangible goals was 111.29%, and the progress rate was 7.77%. Conclusion The PDCA cycle has a significant effect on the quality of outpatient prescriptions by increasing the rate of qualification, improving the quality of hospital pharmacy services, and ensuring the safety of patients.

Key words: rehabilitation pharmacy, prescription analysis, plan-do-check-action(PDCA), rational drug use

CLC Number:

R969.3

LIU Bin, SHAO Meiling, CAI Yiran, MA Fengyi, LAN Hong. Applicability of PDCA cycle in standardization of outpatient prescriptions[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1035-1039.

References

[1] Ministry of Health. Prescription Management measures[S]. Decree No. 53 of the Ministry of Health, 2007.
[2] Management Practices of Hospital Prescription Comment(Trial)[S]. National Health and Family Planning Commission State Administration of Traditional Chinese Medicine issued [2010] No. 28. 2010.
[3] Working Group on the revision of guiding principles for Clinical Application of antimicrobials. Guiding principles for clinical application of antibiotics[M]. Beijing: People’s Health Publishing House, 2015.
[4] ZHAO HQ.Understanding and discussion on prescription evaluation in medical institutions[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2011, 8(8): 477-479.
[5] Ministry of health. Notice of the General Office of the Ministry of Health on printing and distributing the detailed rules for the implementation of evaluation standards for tertiary general hospitals (2011 Edition): wbygf [2011] No.148[EB/OL]. (2011-12-23)[2021-04-02]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=0404f9cd71764ab29b2365e069cfbf2d.
[6] ZHAO XH.Analysis of the application effect of PDCA in the quality management of outpatient and emergency prescriptions[J]. Chinese Prescription Drugs(中国处方药), 2020, 18(10): 45-47.
[7] ZHANG M, WANG CY, Jin YL, et al.Application of PDCA management in key monitoring drug prescription review[J]. Chinese Community Physicians(中国社区医师), 2020, 36(26): 188-189.
[8] GAO SJ.Effect of applying new management method in hospital pharmaceutical management[J]. Continuing Medical Education in China(中国继续医学教育), 2019 ,11(31): 93-95.
[9] ZHAO X, LIN P, GUO J, et al.Pareto diagram analysis of unreasonable drug use in outpatient and emergency departments of our hospital[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2018 , 15(7): 429-433.
[10] ZHEN JC, LU J, MEI D, et al.Standard of pharmaceutical care in medical institutions[J]. Medical Bulletin(医药导报), 2019, 38(12): 1535-1556.
[11] YANG MM, FAN P, WEN CH, et al.Analysis and improvement of problems related to the examination of outpatient prescription pharmacists[J]. China Pharmaceutical Industry(中国药业), 2020, 29(8): 64-67.
[12] LIU XX.Analysis of the current situation of drug use among outpatients in a third-class hospital[J]. Journal of Rational Clinical Drug Use(临床合理用药杂志), 2019, 12(10): 1-2.
[13] FAN P, GAO YY, HE LL, et al.Practice and discussion of pharmacist examination and intervention on promoting clinical rational use of statins[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018,38(19): 2079-2083.
[14] JIANG LW.Study on the causes and countermeasures of unreasonable prescription in western pharmacy[J]. China Medical Guide(中国医药指南), 2020, 18(21): 14-16
[15] ZHAO L, HE XJ, LI XB, et al.Evaluation of drug instructions for cephalosporins commonly used in clinic[J]. Chinese Modern Applied Pharmacy(中国现代应用药学), 2020, 37(15): 1872-1876.
[16] Liu LL.Analysis of unreasonable use of antibiotics in outpatient and emergency respiratory tract infection[J]. Chinese Journd of Pharmacovigilance(中国药物警戒), 2020, 17(8): 513-517
[17] LIU XY, GUO QM, HAN HH, et al.The application effect of quality control circle in improving the reasonable rate of outpatient prescription[J]. Journal of Rational Clinical Drug Use(临床合理用药杂志), 2020, 13(30): 170-172.
[18] HUANG BB.Review and analysis of 1800 outpatient prescriptions in a hospital in 2019[J]. Grass-roots Medical Forum(基层医学论坛), 2020 ,24(25): 3680-3681.
[19] LU YY, LI T, TANG F, et al.Optimization of drug interaction rules in prescription pre-audit system[J]. Chinese Pharmacist(中国药师), 2021, 24(1): 105-108.